- Home
- PACK vs SRZN Comparison
PACK vs SRZN Comparison
Compare PACK & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PACK | SRZN |
|---|---|---|
| Founded | 1972 | 2015 |
| Country | United States | United States |
| Employees | N/A | 44 |
| Industry | Containers/Packaging | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 330.1M | 323.9M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | PACK | SRZN |
|---|---|---|
| Price | $5.62 | $33.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $6.50 | ★ $38.00 |
| AVG Volume (30 Days) | ★ 460.8K | 123.6K |
| Earning Date | 04-30-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $395,000,000.00 | N/A |
| Revenue This Year | $9.29 | $75.35 |
| Revenue Next Year | $8.35 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.08 | N/A |
| 52 Week Low | $2.91 | $7.11 |
| 52 Week High | $6.31 | $33.96 |
Technical Indicators
Market Signals| Indicator | PACK | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 76.10 | 62.04 |
| Support Level | $5.20 | $23.95 |
| Resistance Level | $5.83 | $33.96 |
| Average True Range (ATR) | 0.29 | 2.65 |
| MACD | 0.16 | 0.16 |
| Stochastic Oscillator | 94.84 | 83.60 |
Price Performance
Historical ComparisonAbout PACK Ranpak Holdings Corp
Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).